- Coordinator
- Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eV, Germany
- Runs
- 1 October 2024 to 31 March 2026
- Status
- Running
- EU funding
- €150k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101189408
What the project is doing
In the project's own words, from its summary on CORDIS.
The ecology of Xenorhabdus and Photorhabdus (XP) bacteria requires the production of bioactive natural products against invertebrates, vertebrates, bacteria, and fungi. XPdeter will especially selected metabolites for their application in agriculture. XPdeter aims to (i) validate promising compound classes in the lab and in the field in different bioassays, (ii) create and test a library of synthetically and more accessible derivatives, and (iii) produce the optimized metabolites biotechnologically in XP chassis strains.
Ultimately, the production (iv) of these metabolites will be introduced in Xenorhabdus and Photorhabdus bacteria that already produce potent bioactive natural products in order to achieve extracts showing a combination of different bioactivities. The currently most promising metabolite class, its chemical synthesis and biotechnological production, were all developed as part of the ERC AdG SYNPEP (835108). Within XPdeter we will apply this knowledge to develop a natural product-based, environmentally friendly and economically feasible product that can be combined with or can even replace currently used synthetic and often harmful chemicals in agriculture.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eV | Munchen | Germany | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI